Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1957 ARTÍCULOS , VIENDO DEL 1711 AL 1725

Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy

Sun T, Li Z, Xiao B, Yang J, Han M, Zhang J, Liu S, Ma J, Sang Z, Wang P.

Eur J Med Chem. 2026 Jan 15;302(Pt 3):118383. doi: 10.1016/j.ejmech.2025.118383. Epub 2025 Nov 17.

From genes to lifestyle: A multi-dimensional framework for Alzheimer's disease prevention and therapy

Su L, Wang Y.

Ageing Res Rev. 2026 Jan;113:102947. doi: 10.1016/j.arr.2025.102947. Epub 2025 Nov 19.

Therapeutic potential of third molar-derived dental pulp stem cells in Alzheimer's disease: Current evidence and future directions

Wagaskar P, Suryawanshi M, Patil A, Pardeshi V.

Ageing Res Rev. 2026 Jan;114:102949. doi: 10.1016/j.arr.2025.102949. Epub 2025 Nov 25.

White matter hyperintensity regression: Fact or artifact?

Bahrani AA, Nelson PT, Abner EL, Powell DK, Norris CM, Coskun EP, Stowe AM, Goldstein LB, Van Eldik LJ, Gold BT, Wilcock DM, DeCarli CS, Greenberg SM, Jicha GA.

Neurobiol Aging. 2026 Mar;159:33-46. doi: 10.1016/j.neurobiolaging.2025.12.002. Epub 2025 Dec 3.

Transforming anti-Alzheimer's therapy by targeting endogenous receptorrial system through ligand-conjugated nanoformulations

Gawai M, Nistane N, Tatode AA, Qutub M, Umekar MJ, Premchandani T, Taksande JB.

Ageing Res Rev. 2026 Jan;114:102994. doi: 10.1016/j.arr.2025.102994. Epub 2025 Dec 13.

Targeting brain connectivity in Alzheimer's disease with repurposed drugs

Pini L, Imbimbo BP, Griffa A, Allali G, Pomara N.

Ageing Res Rev. 2026 Jan;114:103001. doi: 10.1016/j.arr.2025.103001. Epub 2025 Dec 18.

Protein and peptide based nanotherapeutics for the management of Alzheimer's disease: Current insights and future directions

Das SK, Bashir B, Kolekar KA, Harish V, Patle D, Vishwas S, Mittal N, Jha SK, Kumar P, Gupta G, Dureja H, Dua K, Chang D, Kuppusamy G, Singh SK.

Ageing Res Rev. 2026 Jan;114:103000. doi: 10.1016/j.arr.2025.103000. Epub 2025 Dec 18.

Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of Alzheimer's Disease

Mishra AK, Jain S.

ACS Chem Neurosci. 2026 Jan 21;17(2):316-334. doi: 10.1021/acschemneuro.5c00750. Epub 2025 Dec 21.

PACAP: A promising disease-modifying target for Alzheimer's disease

Basri R, Al-Kuraishy HM, Fawzy MN, Alruwaili M, Batiha GE.

Life Sci. 2026 Feb 1;386:124176. doi: 10.1016/j.lfs.2025.124176. Epub 2025 Dec 24.

Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer's disease

Soni S, Kaur G.

Cell Calcium. 2026 Jan;133:103107. doi: 10.1016/j.ceca.2025.103107. Epub 2025 Dec 23.

Exercise impact on IRE1α signaling: Novel insights into Alzheimer's disease prevention and treatment

Haixia T, Bo X.

Biochem Biophys Res Commun. 2026 Jan 25;797:153156. doi: 10.1016/j.bbrc.2025.153156. Epub 2025 Dec 18.

Metal-Organic Frameworks as Interfacial Platforms for Early Diagnosis of Alzheimer's Disease

Thokal G, Garg M, Bathinapatla A, Farale H, Kanchi S.

Langmuir. 2026 Jan 13;42(1):32-56. doi: 10.1021/acs.langmuir.5c04804. Epub 2025 Dec 29.

Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure

Garrahy JP.

J Alzheimers Dis. 2026 Feb;109(3):1117-1136. doi: 10.1177/13872877251404970. Epub 2025 Dec 29.

Precision therapeutic strategies for Alzheimer's disease: Amyloid β-targeted foundations and multimodal next-generation approaches

Zafar I, Khan MS, Jamal A, Shafiq S, Bahwerth FS, Khan NU.

Mol Cell Neurosci. 2026 Mar;136:104070. doi: 10.1016/j.mcn.2025.104070. Epub 2025 Dec 30.

Natural glycosides as multi-target neuroprotective agents in Alzheimer's disease: Bridging mechanistic insights and translational potential

Zhou M, Tang S, Zhang Y, Fu G, Yu W, Wang S, Cheng S, Song Z.

Phytomedicine. 2026 Jan;150:157738. doi: 10.1016/j.phymed.2025.157738. Epub 2025 Dec 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias